Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue (Q26830631)

1

1 reference

Michele Patrocínio Rocha

3

1 reference

Cristiano Roberto Grimaldi Barcellos

4

1 reference

Viviane dos Reis Vieira Yance

5

1 reference

José Antonio Miguel Marcondes

6

1 reference

language of work or name

1 reference

2013

1 reference

The Scientific World Journal

5 June 2013

5 references

13 March 2019

24 March 2019

3 April 2019

25 April 2019

11 December 2019

6 references

13 March 2019

24 March 2019

3 April 2019

25 April 2019

11 December 2019

2013

1 reference

page(s)

178364

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

6 references

13 March 2019

24 March 2019

3 April 2019

25 April 2019

11 December 2019

on focus list of Wikimedia project

29 May 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Recent advances in cardiovascular aspects of polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 April 2017

2 references

https://api.crossref.org/works/10.1155/2013/178364

22 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Pathogenesis of insulin resistance in skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Menstrual health and the metabolic syndrome in adolescents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Insulin signaling and glucose transport in insulin resistant human skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Menstrual cycle irregularity and risk for future cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Prevalence of metabolic syndrome in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Laboratorial evaluation and diagnosis of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Metabolic syndrome in young Czech women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F178364

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Exercise-induced increase in glucose transport, GLUT-4, and VAMP-2 in plasma membrane from human muscle

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687487

Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23844380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Exercise induces recruitment of the "insulin-responsive glucose transporter". Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle

1 reference

https://pubmed.ncbi.nlm.nih.gov/23844380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23844380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

1 reference

PubMed publication ID

23844380

1 reference